{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/42385-801#drug","name":"emtricitabine, rilpivirine and tenofovir disoproxil fumarate","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"42385-801"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"ANDA220232"},{"@type":"PropertyValue","propertyID":"UNII","value":"G70B4ETF4S|212WAX8KDD|OTT9J7900I"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"7193c90e-456c-4cfb-8181-65a1618dae51"}],"activeIngredient":"EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, TENOFOVIR DISOPROXIL FUMARATE","administrationRoute":["ORAL"],"dosageForm":"TABLET, FILM COATED","manufacturer":{"@type":"Organization","name":"Laurus Labs Limited"},"drugClass":[],"isAvailableGenerically":true,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/ANDA220232","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7193c90e-456c-4cfb-8181-65a1618dae51","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42385-801"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-02T10:12:42.869Z"}}